Better Buy: Illumina, Inc. vs. Thermo Fisher Scientific
It's been a really good year for Thermo Fisher Scientific (NYSE: TMO). The medical and laboratory instrument maker's stock is up nearly 36% so far in 2017, nearly double the increase for the S&P 500 index. But it's been a really great year for Illumina (NASDAQ: ILMN). The gene-sequencing pioneer's launch of a new system has propelled the stock up almost 67% year to date.
Still, Thermo Fisher Scientific remains the much bigger company, with a market cap of close to $77 billion compared to Illumina's market cap of around $31 billion. Bigger isn't necessarily better, though. Which of these successful stocks is the smarter pick for long-term investors? Here's how Illumina and Thermo Fisher Scientific compare.
Image source: Getty Images.
Source: Fool.com
Illumina Inc. Aktie
Die Illumina Inc. Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Das Kursziel von 161 € für Illumina Inc. weist auf eine Steigerung von über 20% gegenüber dem aktuellen Kurs von 122.54 € hin.
